Insights On Pharmaceutical Packaging

1. Ensuring The Efficacy Of Probiotic Products 10/29/2019

   There is growing interest among consumers in verifying that the dietary supplements they take are safe and efficacious. The concern over whether consumers are getting the product as it is described on the label is rooted in one vital and transformative fact: probiotics are living organisms that are highly sensitive to humidity and oxygen. In the absence of proper handling and packaging, the efficacy of probiotic products can be compromised at any point of the packaging, storage and transportation process, inversely impacting shelf life and product viability and efficacy for the consumer.

2. Clinical Trial Packaging, Labeling And Storage In Horsham, UK 10/11/2019

   This video provides insight into Thermo Fisher Scientific’s primary and secondary packaging of clinical trial materials at the Horsham, UK site. This site also specializes in automated global distribution and in Cold Chain Management.

3. Automatic Cap Welding Machine For Large Volume Parenteral Bottles 2/19/2020

   Weiler Engineering Inc. presents an example of our Automatic Cap Welding Machine for welding Euro, Inso etc. style caps to LVP bottles. The video features 500mL LVP Bottles of LDPE resin produced on our Model 640 Blow/Fill/Seal system.

4. Advanced, Flexible Packaging Solutions To Meet Parenteral Product Demand 11/18/2020

   A service provider has invested heavily in expanding capabilities to meet the growing need for parenteral packaging services to support a range of products from niche, personalized medicines to large-volume treatments.

5. Fit For Purpose Reagents - Packaging 8/21/2020

   This video describes some of the tube and bottle choices available for custom products.

6. PCI Specialty Pharma Center (SPC) 10/22/2020

   PCI Pharma Services has over 50 years’ experience in providing pharmaceutical packaging services covering multiple product types and has established the Specialty Pharma Center (SPC) located in Rockford, Illinois as its’ designated North American location for packaging products deemed to be highly potent requiring specialist handling.

7. What Clinical Teams Should Know About The Benefits Of Auto-Injectors 8/20/2019

   For a host of reasons, auto-injectors are becoming biopharma companies’ delivery method of choice for commercial use and late-stage clinical trials. Auto-injectors ensure that the prescribed dose of medication is delivered fully and completely,making it easier to track compliance in clinical trials.

8. Enabling Biologic Drug Delivery Of Volumes Beyond 1 mL 7/22/2020

   As the biological drug design space evolves toward formulations with larger dose volume and higher viscosity, the device industry is adapting by developing more innovative delivery systems. To accommodate these advances, delivery system manufacturers need to use methodologies and tools to manage conflicting requirements and to offer delivery solutions that balance performance, robustness, and usability while delivering higher volume or viscosity biologics.

9. A Streamlined Scientific Approach To Primary Packaging Solutions For Biologics 1/20/2021

   A particular challenge during the selection of the appropriate primary packaging for an injectable drug product when it comes to biologics is the issue of sensitivity. By some estimates, 20-30% of drug formulations now have sensitivity issues – reacting to one or more elements of their primary packaging and losing their stability. Stevanato Group has developed a product line to address these issues.

10. Expanded Access And Commercial Packaging Strategies For Orphan, Niche, And Low-Volume Drugs 7/20/2020

    Most commercial contract drug packagers do not provide consistent scheduling for low-volume drugs, which creates supply challenges. In fact, a drug packaging delay can create a market shortage that triggers serious health consequences for patients who rely on the drug. This issue can arise with niche and orphan drugs, as well as any other drugs packaged in small volumes. Conversely, a clinical supply partner can provide packaging as needed, plus handle distribution for expanded access and general commercial needs. This summary describes low-volume drugs, examines commercial packaging and supply challenges, and explores potential solutions.